VOYG:NYSEVoyager Technologies, Inc. Analysis
Data as of 2026-06-14 - not real-time
$41.15
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Voyager Technologies (VOYG) is trading at $41.15, comfortably above its 20‑day SMA of 43.76 but still below the 50‑day SMA of 34.96, indicating a consolidation zone between short‑term and intermediate trends. The 14‑day RSI sits near 50.6, suggesting neutral momentum with no clear overbought or oversold pressure. MACD shows a bearish divergence, with the histogram at –0.94 and the signal line above the MACD line, reinforcing short‑term downside bias. Volume trend is decreasing, and the beta of 3.34 points to amplified moves relative to the market, which together amplify the stock’s already high 30‑day volatility of roughly 125%. Technical support is identified around $32.64, while resistance near $52.40 frames a wide trading range that the price must break to confirm a sustained rally.
On the fundamentals side, VOYG trades at a price‑to‑book multiple of about 6.3 and a price‑to‑sales ratio of 14.6, both well above industry averages, while earnings remain negative (PE‑forward –29.8), indicating the market is pricing in aggressive growth expectations. The company’s cash position ($429 M) exceeds its debt ($491 M) but the debt‑to‑equity ratio of 121% and negative free cash flow highlight liquidity pressures. The recent announcement to acquire Astrobotic Technology adds a tangible lunar‑infrastructure asset and aligns with the company’s “Starlab” and Artemis‑related contracts, providing a catalyst that could justify the premium. Analyst consensus remains a “Buy” with a median target of $44, implying modest upside of roughly 8% from the current price. However, the combination of high valuation multiples, bearish short‑term technical signals, and substantial execution risk tempers enthusiasm, suggesting a cautious but optimistic stance.
On the fundamentals side, VOYG trades at a price‑to‑book multiple of about 6.3 and a price‑to‑sales ratio of 14.6, both well above industry averages, while earnings remain negative (PE‑forward –29.8), indicating the market is pricing in aggressive growth expectations. The company’s cash position ($429 M) exceeds its debt ($491 M) but the debt‑to‑equity ratio of 121% and negative free cash flow highlight liquidity pressures. The recent announcement to acquire Astrobotic Technology adds a tangible lunar‑infrastructure asset and aligns with the company’s “Starlab” and Artemis‑related contracts, providing a catalyst that could justify the premium. Analyst consensus remains a “Buy” with a median target of $44, implying modest upside of roughly 8% from the current price. However, the combination of high valuation multiples, bearish short‑term technical signals, and substantial execution risk tempers enthusiasm, suggesting a cautious but optimistic stance.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram
- Decreasing volume trend
- Price below 20‑day SMA
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Astrobotic acquisition expanding lunar capabilities
- Neutral RSI indicating room for upside
- Strong industry tailwinds in space and defense
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strategic positioning at the intersection of space and defense
- Long‑term contracts and backlog growth
- Potential for sustained revenue expansion despite current losses
Key Metrics & Analysis
Financial Health
Revenue Growth2.10%
Profit Margin-72.90%
P/E Ratio-29.8
ROE-54.10%
ROA-11.10%
Debt/Equity121.47
P/B Ratio6.3
Op. Cash Flow$-86301000
Free Cash Flow$-229552256
Industry P/E30.6
Technical Analysis
TrendBullish
RSI50.6
Support$32.64
Resistance$52.40
MA 20$43.76
MA 50$34.96
MA 200$29.87
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Target Price$44.73
Upside/Downside8.69%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta3.34
Volatility124.87%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.